BeStock  
Stocks › Biotechnology › SPTX

Seaport Therapeutics SPTX

US equityMarket cap rank #3270Biotechnology
$17.93 +$0.56 (+3.22%)
Pre-market · Oct 8, 9:10 am ET · After hours $17.93 0.00%
Open$17.28
Prev close$17.37
Day range$17.07 – $18.29
Volume249.1K
Market cap$959.80M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$65.81M-256.3% YoY
Net profit-$62.60M-315.2% YoY
Diluted EPS-$1.78-356.3% YoY
Free cash flow-$26.14M-67.6% YoY
Operating cash flow-$26.14M

Revenue, last 4 quarters

$0.0Mar '25$0.0Jun '25$0.0Mar '26$0.0Jun '26

Net profit, last 4 quarters

$-13.1MMar '25$-15.1MJun '25$-25.4MMar '26$-62.6MJun '26

Diluted EPS by quarter

-0.34Mar '25-0.39Jun '25-0.48Mar '26-1.78Jun '26

Free cash flow by quarter

$-20.3MMar '25$-15.6MJun '25$-20.2MMar '26$-26.1MJun '26

Profitability & balance sheet

Return on equity-31.9%
Return on assets-30.5%
Return on invested capital-33.0%
Current ratio18.00
Liabilities / assets4.3%
Cash & investments$273.31M
Total debt$3.41M
Net cash (debt)$269.90M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Net Profit -$62.60M -$25.41M -$74.88M -$15.08M -$13.13M
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $65.81M $27.54M $87.29M $18.47M $16.19M
Basic EPS -$1.78 -$0.48 -$1.94 -$0.39 -$0.34
Diluted EPS -$1.78 -$0.48 -$1.94 -$0.39 -$0.34
Net Income to Common Stockholders -$62.60M -$25.41M -$74.88M -$15.08M -$13.13M
Net Income to Parent Company -$62.60M -$25.41M -$74.88M -$15.08M -$13.13M
Profit from Continuing Operations -$62.60M -$25.41M -$74.88M -$15.08M -$13.13M
Selling and Admin Expenses $41.19M $6.11M $20.98M $5.06M $5.65M
-General & Admin Expense $41.19M $6.11M $20.98M $5.06M $5.65M
Research & Development $24.62M $21.43M $66.31M $13.41M $10.53M
Operating Profit -$65.81M -$27.54M -$87.29M -$18.47M -$16.19M
Non-Operating Interest Income $3.26M $2.13M $11.40M $2.98M $3.10M
Other Income (Expense) $202,000.00 $521,000.00 $1.78M $551,000.00 -$9,000.00
Other Non-Operating Income (Expenses) $202,000.00 $521,000.00 $1.78M $551,000.00 -$9,000.00
Tax $251,000.00 $519,000.00 $773,000.00 $134,000.00 $31,000.00
Pretax Profit -$62.35M -$24.89M -$74.11M -$14.94M -$13.09M
Net Non-Operating Interest Income (Expense) $3.26M $2.13M $11.40M $2.98M $3.10M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2024 ANNUAL
-Accumulated Depreciation -$1.04M -$1.02M -$989,000.00 -$837,000.00
Investments and Advances $153.95M $30.04M $17.67M $0.00
Other Non-Current Assets $454,000.00 $3.84M $2.88M $454,000.00
Total Liabilities $19.08M $343.29M $341.55M $340.63M
Total Current Liabilities $15.67M $14.22M $12.78M $11.15M
Payables $5.71M $4.80M $2.01M $5.08M
-Accounts Payable $5.71M $4.79M $2.01M $4.73M
-Due to Related Parties Current $0.00 $11,000.00 $7,000.00 $351,000.00
Current Accrued Expenses $5.29M $6.11M $3.94M $2.29M
Short-Term Debt and Capital Lease Obligation $1.61M $1.60M $1.64M $857,000.00
-Gross PPE $6.14M $6.47M $6.21M $6.01M
Net PPE $5.10M $5.45M $5.23M $5.17M
Total Non-Current Assets $159.51M $39.33M $25.78M $5.63M
Total Assets $441.68M $227.67M $249.01M $315.78M
Total Current Assets $282.18M $188.34M $223.23M $310.15M
Cash and Cash Equivalents & Short-Term Investments $273.31M $182.61M $215.98M $309.10M
-Cash and Cash Equivalents $64.22M $52.91M $46.04M $309.10M
-Short Term Investments $209.09M $129.70M $169.94M $0.00
Receivables $4.86M $3.28M $3.03M $0.00
-Accrued Interest Receivable $2.72M $1.38M $1.73M $0.00
-Taxes Receivable $2.14M $1.89M $1.30M $0.00
Prepaid Assets $4.01M $2.46M $4.22M $1.05M
-Current Capital Lease Obligation $1.61M $1.60M $1.64M $857,000.00
-Long Term Capital Lease Obligation $3.41M $3.74M $3.44M $4.15M
Convertible preferred securities $0.00 $325.33M $325.33M $325.33M
Total Equity $422.60M -$115.62M -$92.55M -$24.85M
Stockholders' Equity $422.60M -$115.62M -$92.55M -$24.85M
Capital Stock $5,000.00 $1,000.00 $1,000.00 $1,000.00
-Common Stock $5,000.00 $1,000.00 $1,000.00 $1,000.00
Additional Paid-In Capital $625.19M $23.83M $21.26M $14.38M
Retained Earnings -$202.12M -$139.52M -$114.11M -$39.23M
Total Non-Current Liabilities $3.41M $329.07M $328.77M $329.48M
Long Term Debt and Capital Lease Obligation $3.41M $3.74M $3.44M $4.15M
Gains/Losses Not Affecting Retained Earnings -$475,000.00 $64,000.00 $301,000.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Net Cash Flow from Continuing Financing Activities $240.93M -$783,000.00 -$873,000.00 $0.00 $0.00
Financing Cash Flow $240.93M -$783,000.00 -$873,000.00 $0.00 $0.00
Net Investment Purchase and Sale -$203.50M $27.85M -$183.89M -$1.17M -$225.50M
Net PPE Purchase and Sale $0.00 $0.00 -$356,000.00 -$269,000.00 -$54,000.00
Net cash flow from investing -$203.50M $27.85M -$184.25M -$1.44M -$225.55M
-Change in Other Current Liabilities -$329,000.00 -$323,000.00 -$1.04M -$260,000.00 -$230,000.00
-Change in Other Current Assets $0.00 $0.00 -$1.56M $0.00 -$1.19M
-Change in Payables and Accrued Expense $1.94M $1.29M $877,000.00 $1.93M -$4.10M
-Change in Prepaid Assets -$2.00M $1.57M -$6.21M -$2.84M -$2.66M
Change in Working Capital -$396,000.00 $2.53M -$7.93M -$1.17M -$8.18M
Depreciation & Depletion & Amortization $351,000.00 $357,000.00 $1.41M $354,000.00 $315,000.00
Ending Cash Balance $64.68M $53.36M $46.50M $47.03M $63.80M
Net Change in Cash $11.29M $6.90M -$263.06M -$16.77M -$245.76M
Net Cash Flow from Continuing Investing Activities -$203.50M $27.85M -$184.25M -$1.44M -$225.55M
Free Cash Flow -$26.14M -$20.17M -$78.30M -$15.59M -$20.26M
Effect of Exchange Rate Changes $29,000.00 -$28,000.00 $3,000.00 $0.00 $0.00
Beginning Cash Balance $53.36M $46.50M $309.55M $63.80M $309.55M
Net Income from Continuing Operations -$62.60M -$25.41M -$74.88M -$15.08M -$13.13M
Net cash flow from continuing operations -$26.14M -$20.17M -$77.94M -$15.33M -$20.21M
Operating Cash Flow -$26.14M -$20.17M -$77.94M -$15.33M -$20.21M
Net Other Financing Charges – -$783,000.00 -$874,000.00 – –
Proceeds from Stock Option Exercised – – $1,000.00 – –
Net Preferred Stock Issuance – – $0.00 – –
Gain/Loss from Continuing Operations – – $11,000.00 – –

Discussion

No comments yet — be the first to weigh in on SPTX.

Leave a comment

Scroll to Top